Rhodopsin targeted transcriptional silencing by DNA-binding
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Transcription factors (TFs) operate by the combined activity of their DNA-binding domains (DBDs) and effector domains (EDs) enabling the coordination of gene expression on a genomic scale. Here we show that in vivo delivery of an engineered DNA-binding protein uncoupled from the repressor domain can produce efficient and gene-specific transcriptional silencing. To interfere with RHODOPSIN ( RHO ) gain-of-function mutations we engineered the ZF6-DNA-binding protein (ZF6-DB) that targets 20 base pairs (bp) of a RHOcis -regulatory element (CRE) and demonstrate Rho specific transcriptional silencing upon adeno-associated viral (AAV) vector-mediated expression in photoreceptors. The data show that the 20 bp-long genomic DNA sequence is necessary for RHO expression and that photoreceptor delivery of the corresponding cognate synthetic trans-acting factor ZF6-DB without the intrinsic transcriptional repression properties of the canonical ED blocks Rho expression with negligible genome-wide transcript perturbations. The data support DNA-binding-mediated silencing as a novel mode to treat gain-of-function mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Optical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2013) · Nature · doi:10.1038/nature12466 · Cited by 803
Transcriptional regulation of photoreceptor development and homeostasis in the mammalian retina
Swaroop, A., Kim, D., & Forrest, D. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2880 · Cited by 560 · cited 7×
“The transcriptional repression mechanism of ZF6-DB binding likely relies on the interference occurring between TFs and local DNA sequence features within the RHO proximal promoter region (Mitton et al., 2000), which we showed here to be necessary to control Rho expression at the genomic level.”
BackgroundInfluentialDeconstructing repression: evolving models of co-repressor action
Perissi, V., Jepsen, K., Glass, C. K., & Rosenfeld, M. G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2736 · Cited by 532 · cited 1×
“…on genomic targets and an effector domain (ED) (Brent, 1985; Kadonaga, 2004) that recruits co-activator or co-repressor complexes (Malik and Roeder, 2010; Perissi et al., 2010) resulting in either transcriptional activation or repression of gene regulatory networks (GRNs) (Neph et al., 2012).”
BackgroundCircuitry and Dynamics of Human Transcription Factor Regulatory Networks
Neph, S., Stergachis, A. B., Reynolds, A., Sandstrom, R., Borenstein, E., & Stamatoyannopoulos, J. A. (2012) · Cell · doi:10.1016/j.cell.2012.04.040 · Cited by 467 · cited 1×
“…on genomic targets and an effector domain (ED) (Brent, 1985; Kadonaga, 2004) that recruits co-activator or co-repressor complexes (Malik and Roeder, 2010; Perissi et al., 2010) resulting in either transcriptional activation or repression of gene regulatory networks (GRNs) (Neph et al., 2012).”
BackgroundChemistry and Biology of Vision
Palczewski, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.301150 · Cited by 289
AAV-mediated photoreceptor transduction of the pig cone-enriched retina
Mussolino, C., della Corte, M., Rossi, S., Viola, F., Di Vicino, U., Marrocco, E., Neglia, S., Doria, M., Testa, F., Giovannoni, R., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.3 · Cited by 102
Self-citation
Research works printed but not linked: 25
- Auricchio, 2001, Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column, Human Gene Therapy, 12, 71, 10.1089/104303401450988 · DOI · Paper page
- Beerli, 2002, Engineering polydactyl zinc-finger transcription factors, Nature Biotechnology, 20, 135, 10.1038/nbt0202-135 · DOI · Paper page
- Brent, 1985, A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor, Cell, 43, 729, 10.1016/0092-8674(85)90246-6 · DOI · Paper page
- Daiger BR, 1998, Data services and software for identifying genes and mutations causing retinal degeneration, Investigative Ophthalmology & Visual Science, 39, S295
- Doria, 2013, AAV2/8 vectors purified from culture medium with a simple and rapid protocol transduce murine liver, muscle, and retina efficiently, Human Gene Therapy Methods, 24, 392, 10.1089/hgtb.2013.155 · DOI · Paper page
- Dryja, 1990, Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa, New England Journal of Medicine, 323, 1302, 10.1056/NEJM199011083231903 · DOI · Paper page
- Huber, 2015, Orchestrating high-throughput genomic analysis with bioconductor, Nature Methods, 12, 115, 10.1038/nmeth.3252 · DOI · Paper page
- Kadonaga, 2004, Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors, Cell, 116, 247, 10.1016/S0092-8674(03)01078-X · DOI · Paper page
- Kiang, 2005, Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach, Molecular Therapy, 12, 555, 10.1016/j.ymthe.2005.03.028 · DOI · Paper page
- Kwasnieski, 2012, Complex effects of nucleotide variants in a mammalian cis-regulatory element, Proceedings of the National Academy of Sciences of the United States of America, 109, 19498, 10.1073/pnas.1210678109 · DOI · Paper page
- Lee, 2010, Quantitative fine-tuning of photoreceptor cis-regulatory elements through affinity modulation of transcription factor binding sites, Gene Therapy, 17, 1390, 10.1038/gt.2010.77 · DOI
- Li, 2011, RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome, BMC Bioinformatics, 12, 323, 10.1186/1471-2105-12-323 · DOI · Paper page
- Li, 1996, Transgenic mice carrying the dominant rhodopsin mutation P347S: evidence for defective vectorial transport of rhodopsin to the outer segments, Proceedings of the National Academy of Sciences of the United States of America, 93, 14176, 10.1073/pnas.93.24.14176 · DOI · Paper page
- Liang, 2001, Intraocular delivery of recombinant virus, Methods in Molecular Medicine, 47, 125, 10.1385/1-59259-085-3:125 · DOI · Paper page
- Malik, 2010, The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation, Nature Reviews Genetics, 11, 761, 10.1038/nrg2901 · DOI · Paper page
- Mao, 2011, AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa, Human Gene Therapy, 22, 567, 10.1089/hum.2010.140 · DOI · Paper page
- Mitton, 2000, The leucine zipper of NRL interacts with the CRX homeodomain: a possible mechanism of transcriptional synergy in rhodopsin regulation, Journal of Biological Chemistry, 275, 29794, 10.1074/jbc.M003658200 · DOI · Paper page
- Mussolino, 2011, Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa, EMBO Molecular Medicine, 3, 118, 10.1002/emmm.201000119 · DOI · Paper page
- Pavletich, 1991, Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 a, Science, 252, 809, 10.1126/science.2028256 · DOI · Paper page
- Ptashne, 2014, The chemistry of regulation of genes and other things, Journal of Biological Chemistry, 289, 5417, 10.1074/jbc.X114.547323 · DOI
- R Core Team, 2015, R: A Language and Environment for Statistical Computing
- Roger, 2014, OTX2 loss causes rod differentiation defect in CRX-associated congenital blindness, Journal of Clinical Investigation, 124, 631, 10.1172/JCI72722 · DOI
- Scatchard, 1949, The attractions of proteins for small molecules and ions, Annals of the New York Academy of Sciences, 51, 660, 10.1111/j.1749-6632.1949.tb27297.x · DOI · Paper page
- Surace, 2005, Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer, Molecular Therapy, 12, 652, 10.1016/j.ymthe.2005.06.001 · DOI
- Wickham, 2009, Ggplot2: elegant graphics for data analysis: Springer Science & Business Media, 10.1007/978-0-387-98141-3 · DOI · Paper page
Cited by
Athanasiou, D., Aguila, M., Bellingham, J., Li, W., McCulley, C., Reeves, P. J., & Cheetham, M. E. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.002 · Cited by 373
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 369
Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
Yu, W., Mookherjee, S., Chaitankar, V., Hiriyanna, S., Kim, J.-W., Brooks, M., Ataeijannati, Y., Sun, X., Dong, L., Li, T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14716 · Cited by 271
“For RP caused by a dominant mutation, inactivation of the mutant allele has been evaluated in disease models using ribozymes 8 and RNA interference 9 , and by transcriptional repression using zinc finger-based approaches 10,11 .”
Early and late stage gene therapy interventions for inherited retinal degenerations
Botto, C., Rucli, M., Tekinsoy, M. D., Pulman, J., Sahel, J.-A., & Dalkara, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100975 · Cited by 190
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector
Cideciyan, A. V., Sudharsan, R., Dufour, V. L., Massengill, M. T., Iwabe, S., Swider, M., Lisi, B., Sumaroka, A., Marinho, L. F., Appelbaum, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805055115 · Cited by 147
“The nearly complete suppression of RHO protein expression in WT and RHO-mutant dogs was associated with a loss of the outer segment, similar to the collapse of rod outer segment structure reported by others (36, 55).”
Background
Metadata
- Authors
- Botta, S., Marrocco, E., de Prisco, N., Curion, F., Renda, M., Sofia, M., Lupo, M., Carissimo, A., Bacci, M. L., Gesualdo, C., Rossi, S., Simonelli, F., & Surace, E. M.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2016-03-14
- Volume
- 5
- Pages
- e12242-e12242
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2299697165
- Cited by
- 45
- References
- 7
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- European Research Council (311682)
- Fondazione Telethon (TMESMT211TT)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.